Immediate Impact
52 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Works of Song Qu being referenced
436 A phase II study of AK104, a bispecific antibody targeting PD-1 and CTLA-4, in patients with metastatic nasopharyngeal carcinoma (NPC) who had progressed after two or more lines of chemotherapy
2021
Comparison of three‐dimensional conformal radiotherapy and hepatic resection in hepatocellular carcinoma with portal vein tumor thrombus
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Song Qu | 404 | 461 | 255 | 308 | 97 | 1.0k | |
| Takatsugu Mizumachi | 468 | 337 | 409 | 386 | 66 | 1.1k | |
| J. Biau | 303 | 425 | 242 | 330 | 109 | 1.3k | |
| Nerina Denaro | 469 | 516 | 294 | 373 | 90 | 1.3k | |
| Tomasz Rutkowski | 401 | 246 | 235 | 222 | 92 | 928 | |
| Ling Guo | 276 | 433 | 277 | 321 | 43 | 1.1k | |
| Paweł Golusiński | 387 | 335 | 333 | 537 | 85 | 1.3k | |
| Goshi Nishimura | 456 | 387 | 421 | 222 | 79 | 1.1k | |
| Tyler P. Robin | 165 | 589 | 264 | 330 | 55 | 1.3k | |
| Zhien Feng | 520 | 395 | 431 | 274 | 75 | 998 | |
| Marco Aurélio Vamondes Kulcsar | 319 | 273 | 517 | 254 | 86 | 1.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...